USPTO Rejects Benitec Patent Claims After Initial Review, Company to File Response
September 09, 2005
USPTO Rejects Benitec Patent Claims After Initial Review, Company to File Response
The decision is the latest setback for Benitec in an ongoing legal battle between Benitec and rival Nucelonics that began last April when Benitec sued the company for allegedly infringing a key RNAi patent. Subscribers: click headline for more
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- UniQure, Collaborators Secure $3.2M Eurostar Grant for Huntington’s Disease Effort
May 23, 2013 / Gene Silencing News - NIH Awards $400K to Fund Three microRNA Research Grants in May
May 23, 2013 / Gene Silencing News - Alnylam Releases Proof-of-concept Data on Preclinical Porphyria Drug
May 23, 2013 / Gene Silencing News - MiRagen Hits First Milestone in Servier microRNA Drug Partnership
May 23, 2013 / Gene Silencing News - Cenix to Provide Research Services to Debiopharm
May 23, 2013 / Gene Silencing News